Drug class
Mast-cell stabiliser; antiallergic ophthalmic agent
Mechanism of action
Inhibits antigen-induced mast-cell degranulation and the release of histamine and other inflammatory mediators, in part by limiting calcium-dependent activation. It reduces ocular allergic inflammatory responses.
General use cases
- Treatment of vernal keratoconjunctivitis and other allergic conjunctival disorders with authorised ophthalmic formulations.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
